Home Play-based Intervention for Parents and Infants

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age9-15
SponsorNanyang Technological University

About this trial

The goal of this clinical trial is to learn whether a 12-week home-based intervention (Sociometric Play-based Remediation of Individual Neurodevelopmental Trajectories (SPRINT)) helps support parenting and the development of infants aged 7 - 15 months (at the time they join the study) who were born preterm and/or have a higher family risk of developmental conditions, such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and/or global developmental delay (GDD). The main questions it aims to answer are:

* Does taking part in the SPRINT intervention help parents develop parenting skills? * Does taking part in the SPRINT intervention improve infant's thinking skills and/or socio-emotional development?

Researchers will compare families who receive the SPRINT intervention with families in a waitlist control group to see whether the intervention leads to greater improvements in parents and their children.

Participants will:

* Complete questionnaires and in-person assessments, before and after the 12-week period. * Be assigned to either the SPRINT intervention or a waitlist control group and complete the assigned activities for 12 weeks. * Use the SPRINT app, which provides information, guidance and activities for either the SPRINT intervention or waitlist control group.

Eligibility criteria

Qualifiers

Parent(s) must have access to the internet via a computer, laptop or phone.

Parent (s) with adequate English comprehension skills to participate in the study tasks and provide consent

Disqualifiers

Parent(s) and infants with brain injury, severe motor or sensory impairments (e.g., visual or hearing) that would render them unable to participate in the tasks

Parent(s) diagnosed to have impaired intellectual functioning or mental capacity.

Infants with an identified genetic, metabolic, syndromic, or progressive neurological disorder (e.g., epilepsy, Down or Rett Syndrome, Tuberous Sclerosis, Neurofibromatosis, Fragile X Syndrome), including vascular risk factors

Parent (s) with current or pre-existing diagnosed psychological conditions.

Trial design

Treatments tested in this trial

  • SPRINT Intervention
  • Waitlist Protocol

Treatment groups

120 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Nanyang Technological University

Lead sponsor

Agency for Science, Technology and Research (A*STAR)

Collaborator

KK Women's and Children's Hospital

Collaborator

Institute for Human Development and Potential (IHDP), Singapore

Collaborator